The subcutaneous injection chamber technique has emerged as a valuable tool for cancer patients who are at risk of extravasation during chemotherapy. This method helps to minimize the risk of skin necrosis and reduce the side effects of the drugs being used. Dr. II Luu Kinh Khuong, Head of the Department of Anesthesiology and Resuscitation at Tam Anh General Hospital in Ho Chi Minh City, explained that chemotherapy drugs are typically administered through external intravenous lines, which can damage peripheral blood vessels and increase the risk of extravasation due to vein deviation.
The use of this device allows cancer patients to receive intravenous drug and nutrition infusion without the risks associated with peripheral veins. Extravasation due to chemotherapy is a common complication that can lead to irritation, ulcers, and skin necrosis. This issue is especially prevalent in elderly patients and those with weak vessel walls, obesity, edema, or skin lesions.
Patients who have had a subcutaneous injection chamber placed have reported increased convenience in their daily lives. The device allows for direct transmission of chemotherapy drugs to where they are needed, avoiding complications that may arise from peripheral vein administration. Additionally, the injection chamber can be used for blood testing, fluid administration, and nutrition support for cancer patients who cannot consume orally.
Placing a subcutaneous injection chamber involves inserting a catheter into a central vein either through the neck or below the collarbone. The device is then placed under the skin in the chest area and secured for stability. Patients may experience mild redness and pain at the incision site but these symptoms typically subside within 24-48 hours after placement. It is important for patients to avoid heavy lifting and certain activities in the days following placement of device.
Overall, subcutaneous injection chambers have proven to be an effective tool in reducing extravasation during chemotherapy treatment while improving patient’s quality of life post-procedure. With positive outcomes from this device’s use reported by cancer patients it could become an essential part of modern cancer treatment plans